Samsung Pharmaceutical, Stock Price 8,390 KRW (-8.0%)... Bulletin Board 'Bustling'
At this time, posts about Samsung Pharmaceutical are rapidly increasing on portals and stock communities. Today, foreigners have net sold 15,000 shares of Samsung Pharmaceutical, while institutions have net bought 3,000 shares, according to preliminary data. Samsung Pharmaceutical is known as a leading pharmaceutical company specializing in over-the-counter drugs such as Kaseu Myeongsu.
As of 1:30 PM on the 14th, Samsung Pharmaceutical's stock price is 8.0% lower than the previous day at 8,390 KRW, with a trading volume of 6,880,252 shares, which is about 53.55% of the 5-day average trading volume. On January 12, Samsung Pharmaceutical became a market issue with the headline "Where is the expectation for pancreatic cancer treatment? Sudden plunge."
In addition to Samsung Pharmaceutical, posts by investors are also surging for SG&G (040610), Showbox (086980), and Jeongdawon (208140).
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
※Source: AI Investment Assistant AI Lassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
